in Mild Cognitive Impairment,” Neurobiology of Aging
425, no. 2 (2012): 425e19–27; Matthew Taylor et al.,
“Feasibility and efficacy data from a ketogenic diet
intervention in Alzheimer’s disease,” Alzheimer’s &
Dementia: Translational Research and Clinical
Interventions (2017).
23. S. Djiogue et al., “Insulin Resistance and Cancer: The
Role of Insulin and IGFs,” Endocrine-Related Cancer
20, no. 1 (2013): R1–17.
24. Harber, “Alterations in Carbohydrate Metabolism.”
25. Heikki Pentikäinen et al., “Muscle Strength and
Cognition in Ageing Men and Women: The DR’s
EXTRA Study,” European Geriatric Medicine 8 (2017).
26. Henderson, “Ketone Bodies as a Therapeutic.”
27. E. M. Reiman et al., “Functional Brain Abnormalities in
Young Adults at Genetic Risk for Late-Onset
Alzheimer’s Dementia,” Proceedings of the National
Academy of Sciences USA 101, no. 1 (2004): 284–89.
28. S. T. Henderson, “High Carbohydrate Diets and
Alzheimer’s Disease,” Medical Hypotheses 62, no. 5
(2004): 689–700.
29. Hugh C. Hendrie et al., “APOE ε4 and the Risk for
Alzheimer Disease and Cognitive Decline in African
Americans and Yoruba,” International Psychogeriatrics
26, no. 6 (2014): 977–985.
30. Henderson, “High Carbohydrate Diets.”
31. Konrad Talbot et al., “Demonstrated Brain Insulin
Resistance in Alzheimer’s Disease Patients Is Associated
with IGF-1 Resistance, IRS-1 Dysregulation, and
Cognitive Decline,” Journal of Clinical Investigation
john hannent
(John Hannent)
#1